adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut., 57, 799–806. 23. Giamas,G., Hirner,H., Shoshiashvili,L., Grothey,A., Gessert,S., Kuhl,M., Henne-Bruns,D., Vorgias,C.E. and Knippschild,U. (2007) Phosphorylation of CK1delta: identiﬁcation of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Biochem. J., 406, 389–398. 24. Stoter,M., Bamberger,A.M., Aslan,B., Kurth,M., Speidel,D., Loning,T., Frank,H.G., Kaufmann,P., Lohler,J., Henne-Bruns,D. et al. (2005) Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells. Oncogene, 24, 7964–7975. 25. Tsai,I.C., Woolf,M., Neklason,D.W., Branford,W.W., Yost,H.J., Burt,R.W. and Virshup,D.M. (2007) Disease-associated casein kinase I delta mutation may promote adenomatous polyps forma- tion via a Wnt/beta-catenin independent mechanism. Int. J. Cancer, 120, 1005–1012. 26. Wu,R.C., Qin,J., Yi,P., Wong,J., Tsai,S.Y., Tsai,M.J. and O’Malley,B.W. (2004) Selective phosphorylations of the SRC-3/ AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol. Cell, 15, 937–949. 27. Tora,L., White,J., Brou,C., Tasset,D., Webster,N., Scheer,E. and Chambon,P. (1989) The human estrogen receptor has two inde- pendent nonacidic transcriptional activation functions. Cell, 59, 477–487. 28. Balaguer,P., Francois,F., Comunale,F., Fenet,H., Boussioux,A.M., Pons,M., Nicolas,J.C. and Casellas,C. (1999) Reporter cell lines to study the estrogenic eﬀects of xenoestrogens. Sci. Total Environ., 233, 47–56. 29. Cheng,J., Zhang,C. and Shapiro,D.J. (2007) A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen. Endocrinology, 148, 4634–4641. 30. Behrend,L., Milne,D.M., Stoter,M., Deppert,W., Campbell,L.E., Meek,D.W. and Knippschild,U. (2000) IC261, a speciﬁc inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic eﬀects. Oncogene, 19, 5303–5313. 31. Chen,D., Riedl,T., Washbrook,E., Pace,P.E., Coombes,R.C., Egly,J.M. and Ali,S. (2000) Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell, 6, 127–137. 32. Chen,D., Washbrook,E., Sarwar,N., Bates,G.J., Pace,P.E., Thirunuvakkarasu,V., Taylor,J., Epstein,R.J., Fuller-Pace,F.V., Egly,J.M. et al. (2002) Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-speciﬁc antisera. Oncogene, 21, 4921–4931. 33. Kennelly,P.J. (2003) Archaeal protein kinases and protein phos- phatases: insights from genomics and biochemistry. Biochem. J., 370, 373–389. 34. Kostich,M., English,J., Madison,V., Gheyas,F., Wang,L., Qiu,P., Greene,J. and Laz,T.M. (2002) Human members of the eukaryotic protein kinase family. Genome Biol., 3, RESEARCH0043. 35. Giamas,G., Stebbing,J., Vorgias,C.E. and Knippschild,U. (2007) Protein kinases as targets for cancer treatment. Pharmacogenomics, 8, 1005–1016. 36. Medunjanin,S., Hermani,A., De Servi,B., Grisouard,J., Rincke,G. and Mayer,D. (2005) Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the reg- ulation of receptor activity. J. Biol. Chem., 280, 33006–33014. Nucleic Acids Research, 2009, Vol. 37, No. 9 3123 37. Reid,G., Hubner,M.R., Metivier,R., Brand,H., Denger,S., Manu,D., Beaudouin,J., Ellenberg,J. and Gannon,F. (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell, 11, 695–707. 38. Wijayaratne,A.L. and McDonnell,D.P. (2001) The human estrogen receptor-alpha is a ubiquitinated protein whose stability is aﬀected diﬀerentially by agonists, antagonists, and selective estrogen recep- tor modulators. J. Biol. Chem., 276, 35684–35692. 39. Callige,M., Kieﬀer,I. and Richard-Foy,H. (2005) CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome. Mol. Cell Biol., 25, 4349–4358. 40. Henrich,L.M., Smith,J.A., Kitt,D., Errington,T.M., Nguyen,B., Traish,A.M. and Lannigan,D.A. (2003) Extracellular signal- regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction. Mol. Cell Biol., 23, 5979–5988. 41. Marsaud,V., Gougelet,A., Maillard,S. and Renoir,J.M. (2003) Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), diﬀerentially aﬀect ERalpha extractability, proteasome- mediated stability, and transcriptional activity in human breast cancer cells. Mol. Endocrinol., 17, 2013–2027. 42. Flotow,H., Graves,P.R., Wang,A.Q., Fiol,C.J., Roeske,R.W. and Roach,P.J. (1990) Phosphate groups as substrate determinants for casein kinase I action. J. Biol. Chem., 265, 14264–14269. 43. Oh,A.S., Lahusen,J.T., Chien,C.D., Fereshteh,M.P., Zhang,X., Dakshanamurthy,S., Xu,J., Kagan,B.L., Wellstein,A. and Riegel,A.T. (2008) Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Mol. Cell Biol., 28, 6580–6593. 44. Amazit,L., Pasini,L., Szafran,A.T., Berno,V., Wu,R.C., Mielke,M., Jones,E.D., Mancini,M.G., Hinojos,C.A., O’Malley,B.W. et al. (2007) Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation. Mol. Cell Biol., 27, 6913–6932. 45. Dauvois,S., White,R. and Parker,M.G. (1993) The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci., 106 (Pt 4), 1377–1388. 46. Lee,H. and Bai,W. (2002) Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphoryla- tion. Mol. Cell Biol., 22, 5835–5845. 47. Park,K.J., Krishnan,V., O’Malley,B.W., Yamamoto,Y. and Gaynor,R.B. (2005) Formation of an IKKalpha-dependent tran- scription complex is required for estrogen receptor-mediated gene activation. Mol. Cell, 18, 71–82. 48. Wu,R.C., Smith,C.L. and O’Malley,B.W. (2005) Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr. Rev., 26, 393–399. 49. Zheng,F.F., Wu,R.C., Smith,C.L. and O’Malley,B.W. (2005) Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor. Mol. Cell Biol., 25, 8273–8284. 50. Behrend,L., Stoter,M., Kurth,M., Rutter,G., Heukeshoven,J., Deppert,W. and Knippschild,U. (2000) Interaction of casein kinase 1 delta (CK1delta) with post-Golgi structures, microtubules and the spindle apparatus. Eur. J. Cell Biol., 79, 240–251. 51. Milne,D.M., Looby,P. and Meek,D.W. (2001) Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization. Exp. Cell Res., 263, 43–54.